Sigachi Industries Q2 Results: Revenue Hits Rs 113.48 Crore

Revenue from operations stands at Rs 113.48 crore; Profit After Tax rises to Rs 8.98 crore.

Reader Takeaway: Sequential profit growth and new board appointments indicate operational scaling, though PAT remains lower than year-ago levels.

What just happened

Sigachi Industries Limited has released its unaudited financial results for the quarter ended September 30, 2026. On a standalone basis, the company achieved revenue of Rs 113.48 crore, showing consistent growth from Rs 98.28 crore in the June 2026 quarter and Rs 83.94 crore in the September 2025 quarter. Profit After Tax (PAT) stood at Rs 8.98 crore, a notable recovery from Rs 6.51 crore recorded in the preceding quarter.

Why this matters

The steady climb in revenue highlights sustained demand for the company’s pharmaceutical excipient and chemical portfolio. The decision to onboard Awanindra Kumar Singh as an Additional Whole-Time Director and Sridhara Narasimha Sastry as an Additional Independent Director suggests a strategic push toward professionalizing governance and leveraging their decades of industry experience to drive future operational efficiency.

Board and Management Update

Effective October 31, 2026, the two-year appointments aim to fortify the company's executive and independent oversight. Mr. Singh brings 35 years of pharma expertise, while Mr. Sastry offers nearly four decades of chemical industry leadership, both expected to guide the company through its next phase of expansion.

What to track next

Investors should monitor whether the company can maintain its current revenue momentum and if the new board appointments lead to measurable improvements in consolidated profit margins in upcoming quarters.